Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of the European Academy of Dermatology and Venereology : JEADV|May 7, 2010
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studiesS Prey, C Paul, V Bronsard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 7, 2010
Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologistsC Paul, P-A Gourraud, V Bronsard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 7, 2010
What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literatureV Bronsard, C Paul, S Prey, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 7, 2010
Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literatureS Prey, C Paul, V Bronsard, et al.
International Journal of Immunogenetics|January 3, 2013
16(th) IHIW: global analysis of registry HLA haplotypes from 20 million individuals: report from the IHIW Registry Diversity GroupM Maiers, L Gragert, A Madbouly, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 7, 2010
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literatureE Puzenat, V Bronsard, S Prey, et al.
Genes and Immunity|August 2, 2013
Genetic burden in multiple sclerosis familiesN Isobe, V Damotte, V Lo Re, et al.
Oncogene|November 11, 2009
A 'DNA replication' signature of progression and negative outcome in colorectal cancerM-J Pillaire, J Selves, K Gordien, et al.
Annales De Dermatologie Et De Venereologie|May 24, 2023
Factors associated with early relapse of infantile haemangioma in children treated for at least six months with oral propranolol: A case-control study using the 2014-2021 French Ouest DataHubC Mauguen, A Maruani, S Barbarot, et al.
Cancer Immunology, Immunotherapy : CII|January 23, 2023
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50E Pons-Tostivint, P Hulo, V Guardiolle, et al.
Pageof 5